The Minnesota Partnership for Biotechnology and Medical Genomics has awarded $1.35 million to University of Minnesota and Mayo Clinic researchers seeking new treatments for myelodysplastic syndrome (MDS), a cancer of the blood that impacts the way the human body develops blood cells. The grant will help support the development of pilot studies that could someday result…
Finance & Commerce by Chris Newmarker 3/14/12
Tags: Minnesota Partnership, Minnesota Partnership for Biotechnology and Medical Genomics, Myelodysplatic Syndrome, Research, University of Minnesota